COURAGE - Corticosteroid in acute urticaria in emergency department - P160913

Assistance Publique Hopitaux De Paris0 个研究点目标入组 240 人开始时间: 2024年7月17日最近更新: 2024年8月21日

适应症

试验速览

暂无简介。

•Age > 18 years, Acute urticaria with angioedema without laryngeal edema, Obtain patient’s consent, Social security affiliation

•Pregnancy or breastfeeding, Atopic dermatitis, Eczema, Bullous pemphigoid, Acute exanthematous pustulosis, Diabetes mellitus, Gastrointestinal ulcer, Refusal to participate, Known allergy to the study drugs or formulation ingredients, Hypersensitivity to lactose, Known Renal failure defined by creatinine clearance < 10 mL/min or cardiac failure defined by ejection fraction < 40%, Acute hives with anaphylaxis, Hypersensitivity to active substance, to cetirizine, to hydroxyzine and to pipérazine and excipients, Contre-indication to corticotherapy: o Any live vaccine o Psychotic states still uncontrolled by treatment limiting the participant's compliance with the research o Some viruses in evolution (including hepatitis, herpes, chicken pox, shingles). o Any infectious condition, Bradykinin angioedema, Angioedema without urticaria (hives), Laryngeal edema with urticaria (hives), Corticosteroid administration in the previous 5 days visiting the emergency department, Antihistamines greater than 1 tablet per day in the previous 5 days visiting the ED, Other treatment for urticaria : omalizumab, montelukast, ciclosporine A, Chronic urticaria before acute urticaria diagnosis

发起方